相关实验视频
Updated: Sep 17, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
补充,遗传易感性和异常性肺纤维化风险:一项前性研究
Bingxin Shang1, Yuxin Yao1, Yujia Xie1
1Department of Occupational & Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
补充与患有异常性肺纤维化 (IPF) 的风险更高有关. 这种风险在男性和具有高遗传倾向于IPF的男性中被放大.
科学领域:
- 肺部医学 肺部医学
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 补充剂与异常性肺纤维化 (IPF) 风险之间的关系尚不清楚.
- 异形性肺纤维化 (IPF) 是一种进展性和致命的肺病,治疗选择有限.
研究的目的:
- 调查补充剂与IPF发病率之间的关联.
- 检查遗传敏感性如何改变补充剂对IPF风险的影响.
主要方法:
- 来自英国生物银行的472,468名参与者的分析.
- 利用Cox比例危险模型来评估与补充剂使用相关的IPF风险.
- 计算了IPF特定的多基因风险得分,以评估遗传易感性.
主要成果:
- 补充的使用与IPF风险增加30%有关 (HR:1.30).
- 这种不良关联在男性中更强烈 (P-相互作用:0.037).
- 补充和高遗传风险的个体显示IPF发病率最高 (HR: 3.47).
结论:
- 补充可能是IPF的新风险因素.
- 建议谨慎使用补充剂,特别是在具有遗传倾向的个体中.
- 需要进一步的研究来证实这些发现,并了解潜在的机制.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

